secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEXGEL, INC. (NXGL)
CIK:        0001468929
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001493152-23-040614
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NEXGEL Q3: record revenue $1.2M (+115% YoY), net loss -$550K, gross margin 28.2%
--------------------------------------------------------------------------------

- Revenue $1.2M, up 115% YoY from $568K; growth in contract manufacturing and branded products.
- Gross profit margin 28.2% vs 26.1% YoY, sequentially improved from 15% in Q2 2023.
- Net loss -$550K ($0.10/sh) vs -$1.2M ($0.22/sh) in Q3 2022; improved from -$642K in Q2 2023.
- Operating expenses fell to $956K from $1.185M YoY; cash $3.3M as of Sep 30, 2023.
- New supply agreement with AbbVie (ABBV) for gel pads; Enigma Health retail partnership announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468929/000149315223040614/0001493152-23-040614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468929/000149315223040614/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-040614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer